Recro Gainesville Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RECRO GAINESVILLE, and when can generic versions of RECRO GAINESVILLE drugs launch?
RECRO GAINESVILLE has one approved drug.
There are sixteen US patents protecting RECRO GAINESVILLE drugs.
There are thirty patent family members on RECRO GAINESVILLE drugs in twenty-three countries.
Summary for Recro Gainesville
| International Patents: | 30 |
| US Patents: | 16 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Recro Gainesville
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-006 | Oct 25, 2013 | DISCN | Yes | No | 9,132,096 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-005 | Oct 25, 2013 | DISCN | Yes | No | 10,722,511 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-006 | Oct 25, 2013 | DISCN | Yes | No | 9,713,611 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Recro Gainesville
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-005 | Oct 25, 2013 | 6,228,398 | ⤷ Subscribe |
| Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-004 | Oct 25, 2013 | 6,902,742 | ⤷ Subscribe |
| Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-001 | Oct 25, 2013 | 6,228,398 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for RECRO GAINESVILLE drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Capsules | 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, and 50 mg | ➤ Subscribe | 2014-02-26 |
International Patents for Recro Gainesville Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 107106503 | ⤷ Subscribe |
| Australia | 2020203841 | ⤷ Subscribe |
| Lithuania | 3191085 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
